Phase 4
Completed N=20
The Invia Motion at Cesarean Study
Negative Pressure Wound Therapy · Cesarean Section; Infection
Source: ClinicalTrials.gov NCT04365452 ↗
Enrolled (actual)
20
Serious AEs
0.0%
Results posted
May 2023
Primary outcomePrimary: Pain Scores: Discharge Time Frame — 2.5 score on a scale
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
To assess patient centered outcomes of the Medela INVIA Motion prophylactic NPWT system at cesarean delivery.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain Scores: Discharge Time Frame |
2.5 | — |
| PRIMARY Pain Scores: Scores Postpartum Day 30 |
— | — |
| PRIMARY Patient Satisfaction: Scores Discharge Time Frame |
10 | — |
| PRIMARY Patient Satisfaction: Scores Postpartum Day 30 |
10 | — |
| PRIMARY Patient Satisfaction With Aesthetic Appearance: Scale |
10 | — |
| SECONDARY Wound Infection; Proportion of Incidence |
— | — |
| SECONDARY Wound Separation; Proportion of Incidence |
— | — |
| SECONDARY Seroma; Proportion of Incidence |
— | — |
| SECONDARY Antibiotics Prescribed for Presumed SSI; Proportion of Incidence |
— | — |
| SECONDARY Skin Blistering; Safety Outcomes |
— | — |
| SECONDARY Allergic Reaction; Safety Outcomes |
— | — |
| SECONDARY Wound Bleeding; Safety Outcomes |
— | — |
Eligibility Criteria
Inclusion Criteria
- Scheduled/non-labor or unscheduled/labor cesarean delivery
- Gestational age greater than or equal to 23 weeks
Exclusion Criteria
- Unwilling or unable to provide consent
- Non-availability for postoperative follow-up
- Contraindication to NPWT
Data sourced from ClinicalTrials.gov (NCT04365452). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.